Abstract:Objective To explore the role of RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) pathway in the crosstalk of apoptosis and autophagy in human osteosarcoma HOS cells induced by pyropheophorbide-a methyl ester-mediated photodynamic therapy (MPPa-PDT) and investigate the mechanism by which PERK pathway inhibition enhances the sensitivity of the cells to MPPa-PDT. Methods We first observed the apoptotic morphology of human osteosarcoma HOS cells after MPPa-PDT using Hoechst 33258 staining. HOS cells were treated with MPPa-PDT alone or in combination with a PERK inhibitor (GSK2656157) or an autophagy inhibitor (Bafilomycin A1), and the changes in the expression of the proteins related to PERK pathway (PERK, p-PERK, ATF4, and CHOP), apoptosis (Cleaved caspase-3, Cleaved PARP) and autophagy (LC3-Ⅱ/LC3-Ⅰ and P62) were investigated using Western blotting; the changes in the expression of p-PERK was also examined using immunofluorescence assay. The cell apoptotic rates following the treatments were analyzed using flow cytometry. Results MPPa-PDT resulted in typical morphological changes of apoptosis (nuclear pyknosis and fragmentation) in HOS cells, and induced obvious autophagy and activation of PERK pathway. HOS cells treated with MPPa-PDT, compared with the control cells, showed significantly increased expression of Cleaved caspase-3, Cleaved PARP, LC3-Ⅱ/LC3-Ⅰ, p-PERK, ATF4 and CHOP and lowered expression of P62 and PERK; the cells exhibited stronger green fluorescence signals of p-PERK after MPPa-PDT treatment than the control cells. The application of GSK2656157 significantly blocked MPPa-PDT-induced increases in p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ expression levels, while treatment of the cells with GSK2656157 prior to MPPa-PDT enhanced the cell apoptosis and increased the expression levels of PERK, P62, Cleaved caspase-3 and Cleaved PARP. The cells with combined treatment with MPPa-PDT and GSK2656157 showed weaker green fluorescence signal of p-PERK than those with MPPa-PDT alone. Pretreatment of the cells with Bafilomycin A1 augmented the effects of MPPa-PDT to increase the expression levels of LC3-Ⅱ/LC3-Ⅰ, P62, Cleaved caspase-3 and Cleaved PARP and the apoptosis rate. Compared with the cells with combined MPPa-PDT and GSK2656157 treatment, the cells treated with MPPa-PDT and Bafilomycin A1 showed significantly increased levels of p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ and obviously lowered apoptotic rate and expression levels of PERK, Cleaved caspase-3 and Cleaved PARP. Conclusion The activation of PERK pathway induced by MPPa-PDT may mediate prosurvival autophagy and unfolded protein response, and blocking PERK pathway enhances the killing effect of MPPa-PDT in human osteosarcoma HOS cells.

Antitumor Effects and Mechanisms of Pyropheophorbide‑α Methyl Ester‑mediated Photodynamic Therapy Onthe Human Osteosarcoma Cell Line MG‑63

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Establishment And Characterization Of Human Osteosarcoma Cells Resistant To Pyropheophorbide-Alpha Methyl Ester-Mediated Photodynamic Therapy

Inhibition of PERK pathway enhances sensitivity of human osteosarcoma HOS cells induced to pyropheophorbide-a methyl ester-mediated photodynamic therapy

Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG-63 through the ROS/JNK signaling pathway

Targeting GRP78 enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy via the Wnt/β-catenin signaling pathway

Targeting X Box-Binding Protein-1 (XBP1) Enhances the Sensitivity of HOS Osteosarcoma Cells to Pyropheophorbide- Α Methyl Ester-Mediated Photodynamic Therapy.

Autophagy Inhibitor Enhance ZnPc/BSA Nanoparticle Induced Photodynamic Therapy by Suppressing PD-L1 Expression in Osteosarcoma Immunotherapy.

Antitumor Effect and Mechanism of Hematoporphyrin Monomethyl Ether Mediated Photodynamic Therapy on Sarcoma

Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy Selectively Kills Sarcomas by Inducing Apoptosis.

Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells

Zinc Phthalocyanine Encapsulated in Polymer Micelles As a Potent Photosensitizer for the Photodynamic Therapy of Osteosarcoma.

Intratibial osteosarcoma growth and pulmonary metastasis inhibition by HIPPO signaling pathway-induced photodynamic therapy

Photodynamic-therapy and Chemotherapy of TPBC-PEG Nanoplatform Encapsulated Triptolide Synergistically Inhibit Primary Osteosarcoma Growth and Pulmonary Metastasis by Activating HIPPO Signaling

Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT

Photodynamic Effect of HMME on Cell Line U-2OS and its Mechanism Analysis

Abstract 2878: Hyperthermia increases the efficacy of aminolevulinic acid-mediated photodynamic therapy in human osteosarcoma cells

Pirarubicin Inhibits Multidrug-Resistant Osteosarcoma Cell Proliferation Through Induction of G2/M Phase Cell Cycle Arrest

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Hiporfin-mediated photodynamic therapy in preclinical treatment of osteosarcoma.

Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway